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Background, goals, and results of an




Diabetes mellitus and other noncommu-
nicable diseases (NCDs) present a grow-
ingburden forcountries across theworld,
regardless of their economic situation.
Therefore, the World Health Organiza-
tion (WHO) has developed a global ac-
tionplanfor thepreventionandcontrolof
NCDs[1, 2]. Twokeyobjectivesof the ac-
tionplan are (1) to reducemodifiable risk
factors through a health-promoting en-
vironment and (2) tomonitor trends and
determinants of NCDs. Both goals are
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closely linked through the public health
action cycle. Monitoring and surveil-
lance serve as an essential basis for the
developmentofpreventionmeasures and
their evaluation. Since the launch of the
WHO global action plan in 2013, many
countries have started implementing na-
tional strategies for prevention of NCDs,
including disease surveillance systems.
Workshop goals
For the exchange of best practice exam-
ples regardingNCDsurveillanceandpre-
vention strategies, the Robert Koch In-
stitute (RKI) and the Federal Center for
Health Education (BZgA) jointly orga-
nized a two-day international workshop
in Berlin on June 7–8, 2018. The first day
focused on the implementation of NCD
surveillance activities, formats for timely
andtargeteddisseminationofresults, and
the linktopreventionstrategies. Thetalks
covered the following topics:
4 Development of a national dia-
betes surveillance system in Ger-
many—current status
4 Continuous efforts for strengthening
of data sources to overcome limita-
tions, especially of routine data in
Belgium
4 Development of innovative digital
formats for information dissem-
ination based on examples from
Switzerland and England
4 A systematic approach for the step-
wise expansion from diabetes to
NCD surveillance as implemented in
Canada
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4 Integration of surveillance data
into the evaluation of prevention
programs as shown by the North
Karelia Project in Finland
On the second day, the different ap-
proaches for the development of diabetes
prevention strategies with regard to the
country-specific political environment
and health care systems were discussed,
which was reflected in the presentations:
4 Development of the national aware-
ness and prevention strategy on dia-
betes in Germany—aims, approach,
activities
4 Participatory approach for the suc-
cessful implementation of a diabetes
prevention strategy reflecting the
country-specific stakeholder land-
scape in Austria and Switzerland
4 Continuous adjustment and advance-
ment of diabetes prevention measures
based on surveillance data in a real-
world setting in Finland
4 Development of a primary prevention
program for type 2 diabetes and
its gradual implementation in the
environment of the English health
care system
Results
Presentations on day 1
From diabetes surveillance to NCD
surveillance—Christa Scheidt-
Nave
Diabetes is one of the major NCDs, with
about 6.7million adults affected in Ger-
many [3, 4]. Despite improvements in
screeningandtreatment, personsaffected
bydiabetes still havean increasedmortal-
ity and risk for complications. Therefore,
diabetes is associated with a high societal
burden and costs for the German health
care system. In response to this public
health challenge, the Federal Ministry of
Health commissioned the RKI with the
development of a diabetes surveillance
system.
During the first project phase, a con-
ceptual framework was developed [5]
and consensus on 40 indicators for the
surveillance of diabetes was reached
among experts and stakeholders at the
national and regional level by applying a
two-tier Delphi method [6]. The indica-
tors were assigned to four areas of action:
(1) reducing diabetes risk, (2) improving
diabetes early detection and treatment,
(3) reducing diabetes complications,
and (4) reducing the disease burden
and costs. Both primary data from the
national health surveys and secondary
data from claims data or official statistics
enable the description of indicators and
regular data updates. In order to ensure
the timely and targeted dissemination of
results, the project currently focuses on
improved use and collation of existing
data sources as well as the development
of interactive publication formats.
As many NCDs follow comparable
causal chains with common risk fac-
tors, the diabetes surveillance serves as
a model for surveillance of other NCDs.
The developed conceptual framework,
the established network of stakehold-
ers, and the growing database can act
as leverage for the implementation of




In Belgium, NCDs contribute to 85% of
the total burden of disease, including 2%
due to diabetes. Of persons aged at least
15 years, 28% reported havingmore than
one chronic disease or long-lasting dis-
ability [7]. NCDs have been identified
as a priority in the national Priority to
Chronic Diseases program.
In 2015, the Belgian Federal Minister
of Health launched a plan for integrated
care of chronic diseases: the patient and
his or her environment are at the cen-
ter of a care continuum which works
across silos of providers. The plan aims
to: (1) improve health and equity for all
populations, specifically the chronically
ill; (2) improve the quality, safety, and
experiences of care; and (3) create best
value for public health system resources.
Further NCD targets are formulated at
the federal level, as the competences on,
e. g., health promotion, are distributed.
InformationonNCDsand their deter-
minants are collected through primary
data sources (Health Interview Survey)
and routine data (insurance, general
practitioners, and hospital records). The
latter often focus on care as a clinical
performance measurement rather than
assessing the health of the population.
Overall, disease-specific information
on incidence or prevalence is difficult
to obtain. Efforts should be maintained
to strengthen the data sources for the
surveillance ofNCDs, and to prepare this
information for policy decision-making.
NCD monitoring and knowledge
transfer in Switzerland—Laure
Curt, Wally Achtermann
In Switzerland, cancer, diabetes, cardio-
vasculardiseases, andchronicrespiratory
diseases are responsible for over 50% of
premature mortality (deaths before the
age of 70 years) among men and over
60% among women. Together with mus-
culoskeletal disorders, these five NCDs
account for around 40% of total health
care costs.
In order to address the NCD chal-
lenge, the Federal Office of Public Health
(FOPH) initiated and developed the Na-
tional Strategy on the Prevention of
NCDs (NCD strategy 2017–2024) in
close cooperation with the 26 Swiss
cantons and numerous stakeholders [8].
Since then, the NCD strategy and the
NationalDrug Strategy have replaced the
national programs on alcohol, tobacco,
drugs, diet, and physical activity which
had shaped the federal prevention policy
over the last 20 years.
This new strategy allows the federal
government to focus on the preventionof
NCD risk factors, while disease-specific
strategies such as the national strategy
for cardiovascular diseases, stroke, and
diabetes (CVSD) are drafted and imple-
mented by the cantons and nongovern-
mental public health associations.
Monitoring and research are consid-
ered core activities within one of five ac-
tion fields of the NCD strategy. Overall,
99NCDindicators [9]havebeenselected,
among them seven that relate to diabetes.
These indicators not only survey the de-
velopment of NCDs and their risk factors
in Switzerland, they also assess the long-
term impact of the NCD strategy and its
action plan on population health. The
NCD indicators will be online from au-
tumn 2018.
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National public health system responses to diabetes and other important noncommunicable diseases.
Background, goals, and results of an international workshop at the Robert Koch Institute
Abstract
Diabetesmellitus and other noncommunica-
ble diseases (NCDs) represent an emerging
global public health challenge. In Germany,
about 6.7million adults are affected by
diabetes according to national health surveys,
including 1.3million with undiagnosed
diabetes. Complications of diabetes result
in an increasing burden for individuals and
society as well as enormous costs for the
health care system. In response, the Federal
Ministry of Health commissioned the Robert
Koch Institute (RKI) to implement a diabetes
surveillance system and the Federal Center for
Health Education (BZgA) to develop a diabetes
prevention strategy. In a two-day workshop
jointly organized by the RKI and the BZgA,
representatives from public health institutes
in seven countries shared their expertise
and knowledge on diabetes prevention
and surveillance. Day one focused on NCD
surveillance systems and emphasized both
the strengthening of sustainable data sources
and the timely and targeted dissemination of
results using innovative formats. The second
day focused on diabetes prevention strategies
and highlighted the importance of involving
all relevant stakeholders in the development
process to facilitate its acceptance and
implementation. Furthermore, the effective
translation of prevention measures into real-
world settings requires data from surveillance
systems to identify high-risk groups and
evaluate the effect of measures at the
population level based on analyses of time
trends in risk factors and disease outcomes.
Overall, the workshop highlighted the close
link between diabetes prevention strategies
and surveillance systems. It was generally
stated that only robust data enables effective
prevention measures to encounter the
increasing burden from diabetes and other
NCDs.
Keywords
Diabetes mellitus · Noncommunicable
diseases · Public Health · Surveillance ·
Prevention
Nationale Public-Health-Maßnahmen für Diabetes und andere wichtige nichtübertragbare
Krankheiten. Hintergrund, Ziele und Ergebnisse eines internationalenWorkshops am Robert Koch-
Institut
Zusammenfassung
Diabetes mellitus und andere nichtüber-
tragbare Krankheiten („noncommunicable
diseases“, NCD) stellen global eine wachsende
Herausforderung dar. Gemäß nationalem
Gesundheitssurvey sind in Deutschland
6,7Mio. Erwachsene an Diabetes erkrankt,
davon sind 1,3Mio. Fälle nicht diagnostiziert.
Diabeteskomplikationen führen zu einer
hohen Krankheitslast für Betroffene und
Gesellschaft sowie zu enormen Kosten
für das Gesundheitssystem. Als Reaktion
beauftragte das Bundesministerium für
Gesundheit das Robert Koch-Institut (RKI) mit
der Entwicklung einer Diabetes-Surveillance
und die Bundeszentrale für gesundheitliche
Aufklärung (BZgA) mit der Erarbeitung einer
Aufklärungs- und Kommunikationsstrategie
zu Diabetes. Zum Erfahrungsaustausch
bezüglich dieser beiden Themen organisierten
RKI und BZgA gemeinsam einen 2-tägigen
Workshop mit Fachkundigen aus dem Public-
Health-Bereich aus 7 Ländern. Der erste Tag
behandelte NCD-Surveillance-Systeme und
betonte die Stärkung von Datenquellen
sowie die zeitnahe und zielgerichtete
Veröffentlichung der Ergebnisse mittels
innovativer Formate. Am zweiten Tag wurden
Präventionsstrategien diskutiert und die
Einbindung aller relevanten Stakeholder in
deren Entwicklung unterstrichen, da dies die
Akzeptanz und Implementierung vereinfacht.
Weiterhin werden zur effektiven Umsetzung
von Präventionsmaßnahmen Surveillance-
Daten benötigt, um Hochrisikogruppen zu
identifizieren und den Effekt der Maßnahmen
auf Bevölkerungsebene anhand zeitlicher
Trends von Risikofaktoren und Krankheitsindi-
katoren zu evaluieren. Zusammengefasst zeigt
der Workshop die starke Verbindung zwischen
Präventionsstrategien und Surveillance. Es
wurde betont, dass erst solide Daten effektive
Präventionsmaßnahmen ermöglichen, um der
wachsenden Krankheitslast von Diabetes und
anderen NCD entgegenzuwirken.
Schlüsselwörter
Diabetes mellitus · Nichtübertragbare
Krankheiten · Public Health · Surveillance ·
Prävention
Public Health England’s approach
to NCD surveillance—Justine
Fitzpatrick
The role of Public Health England (PHE)
is to protect and improve the health of
England’s population, and to reduce in-
equalities in health. Surveillance is a core
function of PHE and a guideline setting
the principles of PHE’s surveillance has
been published [10].
A major element of PHE’s NCD
surveillance work is the collation, anal-
ysis, and presentation of data that have
been collected by PHE and other agen-
cies. This analysis is thenused tomonitor
trends in health outcomes, the wider de-
terminants of health, and those elements
of health service use which informpublic
health action. The main presentation
vehicle for PHE’s surveillance activi-
ties is the Fingertips platform (http://
fingertips.phe.org.uk). This platform is
also used for publication of indicators
used for monitoring the government’s
strategy for health improvement, the
Public Health Outcomes Framework
(PHOF).
This PHOF consists of two high-level
indicators for monitoring improvement
in life expectancy and inequalities in
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healthy life expectancy as well as other
indicators organized across the domains
of public health. The Fingertips platform
is also used for diabetes surveillance and
includes indicators for prevalence and
risk, care process, structured education,
treatment targets, and complications.
PHE’s ambition for NCD surveil-
lance is to expand the data sources
used to include more innovative and
digital sources, increase automation of
outputs, expand modelling capabilities,
and develop clearer mechanisms for the
initiation of action based on surveillance
findings.
Surveillance of chronic diseases
in Canada: a collaborative
approach—Louise Pelletier
The Canadian Chronic Disease Surveil-
lance System (CCDSS) is a collabora-
tive network of provincial and territo-
rial surveillance systems supported by
the Public Health Agency of Canada
(PHAC). It started as the National Dia-
betes Surveillance System in 1999.
The CCDSS collects data on all Cana-
dians who are eligible for provincial or
territorialhealthinsuranceandcoversap-
proximately 97% of the population. The
CCDSS can generate national estimates
and trends over time for 19 chronic
diseases, multimorbidities, and direct
health care costs for selected diseases.
The CCDSS identifies disease cases from
provincial and territorial administrative
health databases, including physician
billing claims, hospital discharge ab-
stract records, and publicly funded drug
databases, which are linked to provincial
and territorial health insurance reg-
istry records using a unique personal
identifier (ID). Only aggregated data
are submitted to PHAC, respecting the
provincial and territorial obligations to
protect individual privacy.
Numerous chronic disease surveil-
lance products are generated from the
CCDSS and other data sources (such as
national surveys, vital statistics). These
include the Public Health Infobase,
disease-specific reports, fact sheets, and
infographics. ThePublicHealth Infobase
is of particular interest, since it includes
the CCDSS data tool and the Canadian
Chronic Disease Indicators, which are
updated annually [11]. In addition, the
CCDSSdatasets are available through the
Government of Canada—Open Data.
From a demonstration project to
national action—development of
NCD prevention in Finland—Pekka
Jousilahti
Mortality from coronary heart disease
(CHD) and other NCDs started to in-
crease in Finland in the 1950s In the late
1960s, CHD mortality was the highest
in the world, particularly high among
working-age men in the eastern part of
the country.
The North Karelia Project, a com-
munity-based project aimed at prevent-
ing cardiovascular disease (CVD), was
launched in 1972 [12]. Themain aimwas
toreducethehighmortalityfromCHDby
reductionof the threemainCVDrisk fac-
tors: smoking, high serum cholesterol,
and elevated blood pressure. The project
focused on behavioral change through
community action, supported by screen-
ing of high-risk individuals and medical
treatment. Systematicmonitoring of risk
factors in the population was developed
as part of the project.
Between 1972 and 2012, the levels
of CVD risk factors decreased markedly
[13]. Smoking prevalence fell from 53
to 29% among men. Smoking was rare
among women in the 1970s, and an in-
crease was observed (from 11 to 19%).
In both sexes, serum total cholesterol de-
clinedremarkablyduringthefirst35years
but increased slightly between 2007 and
2012. Mean blood pressure decreased
considerably in both men and women.
From the baseline level in 1969–1972
to2012,CHDmortalitydecreasedby82%
in working-age (35–64 years) men and
by 84% in working-age women. During
the first 10 years, changes in risk factors
contributed to nearly all of the reduction
in CHD mortality. In the 1990s, about
three quarters, and in the last 10 years,
about two thirds of the CHD mortality
reduction could be explained by changes
in the three main CVD risk factors.
Reductions in disease burden and
mortality due to CHD can be achieved
through the use of population-based pri-
mary prevention programs. Secondary
prevention among high-risk individu-
als and treatment of acute CHD events
could confer additional benefit.
Presentations on day 2
The national awareness and
prevention strategy on diabetes in
Germany—Daniela Zahn
The national awareness and prevention
strategy on diabetes in Germany was ini-
tiated by the Federal Ministry of Health
to tackle the challenges associated with
the increasing number of people with
diabetes in order to contribute to the
goals of the Saint Vincent Declaration
[14]: reduce diabetes incidence, improve
early detection and early treatment, and
reduce late complications and improve
quality of life. The German health care
system offers a range of diabetes-related
prevention and care measures. However,
such services are underused. There are
also knowledge deficits concerning dia-
betes as well as a need for more infor-
mation among health care professionals
[15]. Besides this, people with diabetes
often report stigmatization. Thus, the
national awareness and prevention strat-
egy on diabetes in Germany aims at in-
creasing knowledge and awareness about
diabetes and diabetes-specific health lit-
eracy, improving health care use in vul-
nerable groups and decreasing stigmati-
zation.
In order to reach these goals, the strat-
egy’s approach includes a thoroughneeds
assessment, on the basis of which pre-
ventive measures are developed and im-
plemented. To ensure broad acceptance
by relevant stakeholders and to facilitate
long-term implementation of the strat-
egy, a participatory approach by means
of an advisory board including impor-
tant stakeholders (e. g., scientific soci-
eties, patient organizations, health care
professionals, and health insurance com-
panies) is chosen. The next steps are to
develop the strategy’s concept, launch its
planned web-based information system,
and conduct and evaluate preventive ac-
tions according to the strategy’s concept.
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The development of the Austrian
diabetes strategy—a participatory
approach—Raimund Weitgasser
Diabetes represents a major challenge
for health care providers worldwide. In
2016, the Austrian Ministry of Health
and Women’s Affairs initiated the devel-
opment of the Austrian Diabetes Strat-
egy. Main goals of the strategic frame-
work were to reduce the probability of
the Austrian population to develop dia-
betes and to enable people with diabetes
living in Austria to maintain the high-
est possible quality of life for as long as
possible.
The Austrian Diabetes Strategy was
developed by means of a broad partic-
ipatory process, taking into account all
interest groups’ and stakeholders’ input
to support the successful and sustainable
implementation of the strategy. More
than 100 decision-makers—experts and
representatives of the national govern-
ment, federal states, social insurance in-
stitutions, self-help groups, and profes-
sional representatives—were invited to
participate. Five relatively small effective
working groups were formed to define
the strategy’s objectives and recommen-
dations. An even broader range of stake-
holders were invited to comment on the
draft version of the strategy. The final
version was peer reviewed by two inter-
national experts.
The strategy contains six broad ob-
jectives such as improving diabetes-spe-
cific knowledge in the general population
(goal 01) or empowering diabetes pa-
tients with respect to self-management
(goal 03), as well as specific recommen-
dations on how to reach these objectives.
Based on the strategy, an action plan in-
cluding measurable outcomes will be de-
veloped with all relevant partners [16].




In 2016, the joint platform for dialogue
on national health policy set up by the
federal and cantonal governments devel-
oped the Swiss National Strategy for the
Prevention of NCDs, envisioning that
“more people (should) stay healthy or en-
joy a high quality of life despite chronic
illness” and “fewer people (should) con-
tract avoidableNCDsordieprematurely”
[8]. In parallel, a large number of profes-
sional societies and organizations from
the health care system, patient organiza-
tions, leagues, and other relevant players
have developed a disease-specific strat-
egy for cardiovascular diseases and dia-
betes [17]. This strategy was developed
using an inter-professional and interdis-
ciplinary participative process under the
leadership of the network CardioVasc
Suisse.
Supplementing the Swiss National
Strategy for the Prevention of NCDs, the
strategy for CVDs and diabetes aims to
strengthen prevention and early detec-
tion, promote high-quality, integrated,
and patient-centered care for chronically
ill and multimorbid patients, optimize
acute care of heart attack and stroke,
reinforce coordination and coopera-
tion at all levels, improve the available
data(bases) for Switzerland, and close
funding gaps and improve the health
policy framework [17]. Priorities with
regard to diabetes were: identifying per-
sons at risk, promoting best practice
guidelines as well as interdisciplinary
care, to empower people with diabetes,
and to improve knowledge regarding
complications and access to optimal
treatment and care [17]. Furthermore,
the strategy aims to improve the quality
of epidemiological data and promote
a Swiss Diabetes Registry. The strategy
defines objective specific measures and
assigns authorities to be responsible for
the implementation of such measures.
This will be done in consultation with
the Steering Committee of the strategy
and the Coordination Office.
Prevention of type 2 diabetes
in Finland—challenges,
lessons learnt, and recent
advancements—Jaana Lindström
Type 2diabetes is a great challenge for the
health care systemalso inFinland, due to,
e. g., population ageing, increasing obe-
sity, and changes in lifestyle. In order to
tackle the epidemic, health promotion
activities targeted at the whole popula-
tion are mandatory. In addition, actions
directed toward individuals and popula-
tion groups at increased risk are needed.
The Finnish Diabetes Prevention Study
(DPS) was the first controlled, individu-
ally randomized clinical trial to show that
type 2 diabetes is preventable by lifestyle
intervention. Follow-up of the studypar-
ticipants further demonstrated that the
effect of intervention can be sustained
for several years.
The results of the clinical trial were
soon put into practice as Finland started
the national diabetes program (DEHKO
2000–2010) and its implementation pilot
project FIN-D2D (2003–2008) led by the
Finnish Diabetes Association. The pilot
project included a strong and novel com-
ponent of risk identification and preven-
tion of diabetes. Positive learnings from
FIN-D2D include the recognition of im-
portance of risk screening andpreventive
services provided by the health care sys-
tem. Still, challenges such as behavioral
maintenance, changing health care sys-
tems, and changing societies and living
environments need to be addressed with
new strategies.
StopDia is anon-goingnational initia-
tive aiming at stopping diabetes by three
levels of action: individual, environmen-
tal, and societal, with strong theoretical
background and use of digital solutions.
To make the uptake of new models like
StopDia feasible for society, considera-
tion of new innovative funding mecha-




the National Health Service
(NHS) Diabetes Prevention
Program—Jonathan Valabhji
The increase in prevalence of overweight,
obesity, and type 2 diabetes has implica-
tions for the sustainability of health sys-
tems internationally. In 2014, the NHS
in England committed to becoming the
first country to implement a national ev-
idence-based type 2 diabetes prevention
program (DPP).
The Healthier You: NHS DPP was
launched in 2015, and the ambition of
universal national coverage will be real-
ized in Summer 2018 [18]. Interventions
involve an initial assessment and at least
13 face-to-face group-based sessions, in-
volving at least 16h of contact time over
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at least 9 months. First-year data have
beenpublished [19]. By the end ofMarch
2018, theprogramhadachieved75%cov-
erageofEngland; 182,000individualshad
been referred into the program, with 59%
conversion to attendance at initial assess-
ment. Completion rates for those who
attend the first intervention session are
52%, andmeanweight loss in completers
is 3.3kg.
A digital component to the program,
offering remotedelivery, will recruit 5000
individuals with a formal evaluation to
assess effectiveness in real-world envi-
ronments and will report in late 2019.
An independent evaluation assessing ef-
fectsof the fullprogramontype2diabetes
incidence in England will report in 2021.
Conclusion
Following theWHOcall for action, many
countries responded to the growing bur-
den from NCDs. Both a reliable disease
surveillance system and an aligned pre-
ventionstrategyareessentialpartsoftheir
responses. However, approaches differ
mainly between countries, influenced by
the country-specific health care system
and political environment.
Both Germany and Belgium are in
the early stages of developing an NCD
surveillance system. For its implementa-
tion, reliable data sources—bothprimary
and secondary—are key, and continuous
effort isneeded tostrengthenandvalidate
the available data. A strong and sustain-
able surveillance system is crucial to both
the identification of high-risk groups and
for the evaluationofpreventivemeasures.
Thishasalreadybeendemonstratedinthe
Finnish North Karelia Project and is also
becoming evident in the ongoing evalu-
ation of the National Health Service Di-
abetes Prevention Program in England.
For timely dissemination of surveillance
data, innovative digital formats can be
used, such as the Fingertips Platform
in the UK or comparable platforms in
Canada and Switzerland.
The discussion on the development of
preventive strategies highlighted the im-
portance of a participatory approach to
facilitate the acceptance and implemen-
tation of a strategy, as shown in Aus-
tria and Switzerland. As demonstrated
by the long-standing experiences in Fin-
land, preventive measures can be effec-
tively and successfully implemented in a
real world setting. However, the imple-
mentation of a sustainable strategy needs
sound funding. New models such as the
Social ImpactBond inFinlandmay intro-
duce new funding opportunities. In gen-
eral, targeting vulnerable groups as well
as tailoring interventions to population
characteristics and needs has been em-
phasized. This may be achieved by using
new digital technologies, lowering barri-
ers to health care use, or addressing en-
vironmental determinants. Continuous
(re-)adjustment of preventive measures
based on local context and surveillance
data is crucial.
Above all, the workshop demon-
strated the close link between diabetes
prevention strategies and surveillance as
well as the coordination of both in order
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